Cargando…

Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells

BACKGROUND: The peptide hormone calcitonin (CT) can significantly effect the proliferation rate of CT receptor (CTR) positive human cancer cells. We wish to identify additional human cancers expressing CTRs and assay the effects of CT on their growth rates and signal transduction pathways. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mould, Richard, Pondel, Marc D
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC155681/ https://www.ncbi.nlm.nih.gov/pubmed/12747809 http://dx.doi.org/10.1186/1475-2867-3-6

Ejemplares similares

Induction of GD3/α1-adrenergic receptor/transglutaminase 2-mediated erythroid differentiation in chronic myelogenous leukemic K562 cells
por: Ha, Sun-Hyung, et al.
Publicado: (2017)

Sirtuin 1 inhibits lipopolysaccharide-induced inflammation in chronic myelogenous leukemia k562 cells through interacting with the Toll-like receptor 4-nuclear factor κ B-reactive oxygen species signaling axis
por: Wang, Lei, et al.
Publicado: (2020)

CDA gene silencing regulated the proliferation and apoptosis of chronic myeloid leukemia K562 cells
por: Wei, Xiao-Fang, et al.
Publicado: (2018)

Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
por: Wang, Yu Jia, et al.
Publicado: (2017)

Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells
por: Prado-Carrillo, Omar, et al.
Publicado: (2022)

Cloning and transcriptional analysis of the mouse receptor activity modifying protein-1 gene promoter
por: Pondel, Marc D, et al.
Publicado: (2005)

Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells
por: Huang, Huey-Lan, et al.
Publicado: (2011)

Prodigiosin induced the caspase-dependent apoptosis in human chronic myelogenous leukemia K562 cell
por: Niakani, Maryam, et al.
Publicado: (2020)

Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells
por: Shi, Dan, et al.
Publicado: (2016)

Curcumin and Curcumin-Loaded Nanogel Induce Apoptosis Activity in K562 Chronic Myelogenous Leukemia Cells
por: Khatamsaz, Sepideh, et al.
Publicado: (2018)

CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
por: Chang, Guoqiang, et al.
Publicado: (2013)

Polyamine analog TBP inhibits proliferation of human K562 chronic myelogenous leukemia cells by induced apoptosis
por: WANG, QING, et al.
Publicado: (2015)

Human Platelets Effectively Kill K‐562 Cells, a Chronic Myelogenic Leukemia Cell Line, in vitro
por: Sagawa, Terutaka, et al.
Publicado: (1990)

Proton NMR visible mobile lipid signals in sensitive and multidrug-resistant K562 cells are modulated by rafts
por: Mannechez, Aurélie, et al.
Publicado: (2005)

Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin
por: Rai, Yogesh, et al.
Publicado: (2019)

Cytotoxic effects of the compound cis-tetraammine(oxalato)ruthenium(III) dithionate on K-562 human chronic myelogenous leukemia cells
por: Pereira, Flávia de Castro, et al.
Publicado: (2014)

Effect of bovine dialyzable leukocyte extract on induction of cell differentiation and death in K562 human chronic myelogenous leukemia cells
por: Sierra-Rivera, Crystel A., et al.
Publicado: (2016)

Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition
por: Li, Lv, et al.
Publicado: (2012)

Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids
por: Miller, Aaron L, et al.
Publicado: (2007)

Influence of RARα gene on MDR1 expression and P-glycoprotein function in human leukemic cells
por: Stromskaya, Tatjana P, et al.
Publicado: (2005)

Inhibition of abl Oncogene Tyrosine Kinase Induces Erythroid Differentiation of Human Myelogenous Leukemia K562 Cells
por: Honma, Yoshio, et al.
Publicado: (1990)

A polymethoxyflavone from Laggera pterodonta induces apoptosis in imatinib-resistant K562R cells via activation of the intrinsic apoptosis pathway
por: Cao, Changshu, et al.
Publicado: (2014)

C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells
por: Brognara, Eleonora, et al.
Publicado: (2011)

Efficacy of in vitro treatment of chronic myelogenous leukemia cell line, K562 cells, using 4-hydroperoxycyclophosphamide, alpha-interferon and gamma-interferon.
por: Lee, J. T., et al.
Publicado: (1996)

Megakaryocytic differentiation in human chronic myelogenous leukemia K562 cells induced by ionizing radiation in combination with phorbol 12-myristate 13-acetate
por: Hirose, Katsumi, et al.
Publicado: (2013)

Iron removal enhances vitamin C-induced apoptosis and growth inhibition of K-562 leukemic cells
por: Tsuma-Kaneko, Mitsuyo, et al.
Publicado: (2018)

Fangchinoline induces G0/G1 arrest by modulating the expression of CDKN1A and CCND2 in K562 human chronic myelogenous leukemia cells
por: WANG, YUPING, et al.
Publicado: (2013)

HOXB1 restored expression promotes apoptosis and differentiation in the HL60 leukemic cell line
por: Petrini, Marina, et al.
Publicado: (2013)

Involvement of CD147 on multidrug resistance through the regulation of P-glycoprotein expression in K562/ADR leukemic cell line
por: Somno, Aoranit, et al.
Publicado: (2016)

Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity
por: Long, Mark D., et al.
Publicado: (2015)

Jellyfish extract induces apoptotic cell death through the p38 pathway and cell cycle arrest in chronic myelogenous leukemia K562 cells
por: Ha, Sun-Hyung, et al.
Publicado: (2017)

Chronic Myelogenous Leukemia Cells Contribute to the Stromal Myofibroblasts in Leukemic NOD/SCID Mouse In Vivo
por: Shirasaki, Ryosuke, et al.
Publicado: (2012)

Rapamycin enhanced the antitumor effects of doxorubicin in myelogenous leukemia K562 cells by downregulating the mTOR/p70S6K pathway
por: Li, Jie, et al.
Publicado: (2019)

Hereditary asplenic-athymic mice: transplantation of human myelogenous leukemic cells
Publicado: (1976)

Induction of in vitro proliferation and maturation of human aneuploid myelogenous leukemic cells
Publicado: (1982)

Leukemic retinophaty, the first manifestation in a case of acute myelogenous leukemia
por: Scripcă, Oana Roxana, et al.
Publicado: (2018)

Isorhamnetin 3-O-robinobioside from Nitraria retusa leaves enhance antioxidant and antigenotoxic activity in human chronic myelogenous leukemia cell line K562
por: Boubaker, Jihed, et al.
Publicado: (2012)

Olive (Olea europaea) Leaf Extract Induces Apoptosis and Monocyte/Macrophage Differentiation in Human Chronic Myelogenous Leukemia K562 Cells: Insight into the Underlying Mechanism
por: Samet, Imen, et al.
Publicado: (2014)

4-Nerolidylcatechol: apoptosis by mitochondrial mechanisms with reduction in cyclin D1 at G0/G1 stage of the chronic myelogenous K562 cell line
por: Benfica, Polyana Lopes, et al.
Publicado: (2017)

Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis
por: Wang, Wenjing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_91clmgriqk4f4m2qfhjnd52bop